U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07213713) titled 'Evaluation of Anti-Xa Activity in Patients With Severe Obesity After Subcutaneous Injection of Enoxaparin for Antithrombotic Prophylaxis at Two Different Sites.' on Oct. 02.
Brief Summary: To evaluate appropriateness of enoxaparin bioavailability at two different sites of subcutaneous administration (arms or abdomen) in primary or secondary prevention of thromboembolism in a population of patients with severe obesity
Study Start Date: Oct. 01
Study Type: OBSERVATIONAL
Condition:
Venous Thromboembolism
Obese Patients
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Inf...